Pricing Log in Create free account

Ginkgo Bioworks Holdings, Inc. (DNA) vs Sagimet Biosciences Inc. (SGMT)

Ginkgo Bioworks Holdings, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Sagimet Biosciences Inc. are of similar size ($670.7M and $641.5M). Sagimet Biosciences Inc. has the higher net margin (0.00% vs −260.0%) and the lower return on invested capital (−205.2% vs −161.9%). Across the 13 metrics below, Sagimet Biosciences Inc. leads on 8 and Ginkgo Bioworks Holdings, Inc. on 5.

Valuation

Metric DNA SGMT Biotechnology median
P/E n/m n/m 10.60
P/S 6.21 n/m 9.40
P/B 1.65 2.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.05 n/m 9.02
Earnings yield (44.77%) (13.03%) (32.88%)
Free cash flow yield (25.07%) (8.00%) (23.13%)

Profitability

Metric DNA SGMT Biotechnology median
Gross margin 80.55% 0.00% 68.51%
Operating margin (273.61%) 0.00% 0.00%
Net margin (259.96%) 0.00% 0.00%
Free cash flow margin (155.75%) 0.00% 0.00%
Return on equity (56.29%) (24.37%) (51.96%)
Return on assets (26.19%) (23.49%) (46.06%)
Return on invested capital (161.94%) (205.24%) 0.00%

Growth

Metric DNA SGMT Biotechnology median
Revenue growth (TTM) (51.54%) — 6.76%
EPS growth (last fiscal year) 46.49% (8.97%) 29.88%
Revenue growth, 5-year CAGR 17.29% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNA SGMT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.57 45.02 4.97
Net debt to EBITDA 1.63 1.98 1.01

Dividend

Metric DNA SGMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DNA SGMT Biotechnology median
Market cap 670.71m 641.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack